Literature DB >> 21055659

Mechanisms of immunotherapy: a historical perspective.

Ebrahim M Shakir1, Dorothy S Cheung, Mitchell H Grayson.   

Abstract

OBJECTIVE: To provide a historical review of mechanisms proposed during the last century to explain the efficacy of immunotherapy. DATA SOURCES: We retrieved review articles and original research from MEDLINE, OVID, and PubMed that addressed our topic of interest. STUDY SELECTION: Articles were selected for their relevance to immunotherapy and mechanisms.
RESULTS: Early studies focused on the production of blocking antibodies induced by immunotherapy, with mechanistic explanations aimed at understanding a relationship between blocking antibodies and clinical response. This was followed by a period when the effects of immunotherapy on levels and function of effector cells in the allergic response were studied. Aiding in characterization of this response was the discovery of IgE and its role in allergic sensitization, which brought a renewed focus on the antibody-mediated effects of immunotherapy. In an attempt to create a unifying hypothesis to explain humoral and cellular mechanisms of immunotherapy, recent approaches have been focused on the role of the T cell and, specifically, regulatory T cells.
CONCLUSIONS: Although the clinical practice of immunotherapy has been refined since its introduction 100 years ago, our understanding of the mechanisms that underlie this success has awaited discoveries in basic immunology.
Copyright © 2010 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 21055659     DOI: 10.1016/j.anai.2010.09.012

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

1.  Immunotherapy with B cell epitopes ameliorates inflammatory responses in Balb/c mice.

Authors:  P Sharma; S N Gaur; N Arora
Journal:  Clin Exp Immunol       Date:  2015-01       Impact factor: 4.330

Review 2.  Convalescent plasma in Covid-19: Possible mechanisms of action.

Authors:  Manuel Rojas; Yhojan Rodríguez; Diana M Monsalve; Yeny Acosta-Ampudia; Bernardo Camacho; Juan Esteban Gallo; Adriana Rojas-Villarraga; Carolina Ramírez-Santana; Juan C Díaz-Coronado; Rubén Manrique; Ruben D Mantilla; Yehuda Shoenfeld; Juan-Manuel Anaya
Journal:  Autoimmun Rev       Date:  2020-05-05       Impact factor: 9.754

Review 3.  Desensitization for the prevention of drug hypersensitivity reactions.

Authors:  Sung-Yoon Kang; Jeongmin Seo; Hye-Ryun Kang
Journal:  Korean J Intern Med       Date:  2022-02-28       Impact factor: 2.884

4.  Allergenic characterization of new mutant forms of Pru p 3 as new immunotherapy vaccines.

Authors:  C Gómez-Casado; M Garrido-Arandia; P Gamboa; N Blanca-López; G Canto; J Varela; J Cuesta-Herranz; L F Pacios; A Díaz-Perales; L Tordesillas
Journal:  Clin Dev Immunol       Date:  2013-11-14

Review 5.  Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow.

Authors:  O Garraud; F Heshmati; B Pozzetto; F Lefrere; R Girot; A Saillol; S Laperche
Journal:  Transfus Clin Biol       Date:  2016-01-06       Impact factor: 1.406

6.  Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis.

Authors:  Laura Skrip; Karim Derra; Mikaila Kaboré; Navideh Noori; Adama Gansané; Innocent Valéa; Halidou Tinto; Bicaba W Brice; Mollie Van Gordon; Brittany Hagedorn; Hervé Hien; Benjamin M Althouse; Edward A Wenger; André Lin Ouédraogo
Journal:  Int J Infect Dis       Date:  2020-09-26       Impact factor: 3.623

Review 7.  Convalescent plasma - Is it useful for treating SARS Co-V2 infection?

Authors:  Sudha Ranganathan; Ranganathan N Iyer
Journal:  Indian J Med Microbiol       Date:  2020 Jul-Dec       Impact factor: 0.985

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.